Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BY-NC-NDAsia-Pacific journal of oncology nursing

Comprehensive needs among patients with gastrointestinal cancer receiving chemotherapy: A cross-sectional latent profile analysis.

  1. 1The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

Abstract

To identify latent profiles of comprehensive needs among patients with gastrointestinal cancer receiving chemotherapy and examine factors associated with profile membership. This cross-sectional study included 341 adults with gastrointestinal cancer receiving chemotherapy at a tertiary hospital in Qingdao, China, from October 2024 to June 2025. Participants completed the Comprehensive Needs Assessment Tool in Cancer (CNAT), Strategies Used by People to Promote Health, Family APGAR Index, Comprehensive Scores for Financial Toxicity based on Patient-Reported Outcome Measures, and Fear of Progression Questionnaire-Short Form. Latent profile analysis was conducted using the eight CNAT domain scores. Factors associated with profile membership were examined using multinomial logistic regression with the three-step approach. Three profiles were identified based on most likely class membership: low needs-information priority group (38.1%), moderate needs-balanced group (40.5%), and high needs-medical priority group (21.4%). Education level, primary tumor site, number of chemotherapy cycles, stage, financial toxicity, self-management efficacy, and fear of progression were associated with profile membership. Comprehensive needs varied across three latent profiles. These exploratory profiles may support stratified needs assessment and supportive care planning. External validation in multicenter prospective studies is required before profile-based care is implemented.

Related

  1. Longitudinal Association Between the Change in Serum Procollagen Type III N-Terminal Peptide (PIIINP) and Skeletal Muscle Loss in Patients with Gastrointestinal Cancer Receiving Chemotherapy: A Prospective Cohort Study
    Mehmet Erdinç Esenkaya, Özlem Özdemir, Mustafa Değirmenci +3
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  2. Association of co-administration of neurokinin-1 receptor antagonists and dexamethasone with new-onset diabetes in patients receiving chemotherapy: a retrospective cross-sectional study using health claims database in Japan.
    Yuki Ozawa, Shinya Suzuki, Takuma Koinuma +5
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  3. Comparative Short-Term Risk of Severe Gastrointestinal Events Associated with Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
    Sungho Bea, Elisabetta Patorno, Sushama Kattinakere Sreedhara +5
    Diabetes carePeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
  4. Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study
    Zirui Xue, Dan Liu, Zhaodong Sun +6
    Cancer reports (Hoboken, N.J.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Barriers and facilitators to self-management among patients with breast cancer receiving neoadjuvant chemotherapy: A qualitative study informed by the integrated theory of health behavior change
    Yanling Jiang, Chaixiu Li, Yinhuan Wang +3
    Asia-Pacific Journal of Oncology NursingPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{shan2026comprehensive,
  title = {{Comprehensive needs among patients with gastrointestinal cancer receiving chemotherapy: A cross-sectional latent profile analysis.}},
  author = {Hui Shan and Hongyan Zhang and Nannan Song and Weiwei Bing and Lili Wei and Fang Liu},
  journal = {Asia-Pacific journal of oncology nursing},
  year = {2026},
  month = sep,
  doi = {10.1016/j.apjon.2026.101038},
  url = {https://europepmc.org/article/MED/42997015},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Comprehensive needs among patients with gastrointestinal cancer receiving chemotherapy: A cross-sectional latent profile analysis.
AU  - Hui Shan
AU  - Hongyan Zhang
AU  - Nannan Song
AU  - Weiwei Bing
AU  - Lili Wei
AU  - Fang Liu
PY  - 2026
DA  - 2026/09/24
JO  - Asia-Pacific journal of oncology nursing
DO  - 10.1016/j.apjon.2026.101038
UR  - https://europepmc.org/article/MED/42997015
AB  - To identify latent profiles of comprehensive needs among patients with gastrointestinal cancer receiving chemotherapy and examine factors associated with profile membership. This cross-sectional study included 341 adults with gastrointestinal cancer receiving chemotherapy at a tertiary hospital in Qingdao, China, from October 2024 to June 2025. Participants completed the Comprehensive Needs Assessment Tool in Cancer (CNAT), Strategies Used by People to Promote Health, Family APGAR Index, Comprehensive Scores for Financial Toxicity based on Patient-Reported Outcome Measures, and Fear of Progression Questionnaire-Short Form. Latent profile analysis was conducted using the eight CNAT domain scores. Factors associated with profile membership were examined using multinomial logistic regression with the three-step approach. Three profiles were identified based on most likely class membership: low needs-information priority group (38.1%), moderate needs-balanced group (40.5%), and high needs-medical priority group (21.4%). Education level, primary tumor site, number of chemotherapy cycles, stage, financial toxicity, self-management efficacy, and fear of progression were associated with profile membership. Comprehensive needs varied across three latent profiles. These exploratory profiles may support stratified needs assessment and supportive care planning. External validation in multicenter prospective studies is required before profile-based care is implemented.
SN  - 2347-5625
SN  - 2349-6673
ER  -